Recently, using a murine model of melanoma, intradermal IL-12 GET plus DNA vaccination combined with anti-CTLA4/PD-1 blockade led to tumor reduction through long-lasting antigen-specific IgG antibodies together with antigen-specific CD8+ T cells [174]. This evidence concerns the gene CTLA4 and melanoma.